StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
002215.SZ$9.07+1.65%
Fair $9.07+0.0%

002215.SZ

Shenzhen Noposion Crop Science Co., Ltd.

Basic Materials / Agricultural InputsShenzhen

$9.07

+0.15 (+1.65%)

Fairly Valued+0.0%Fair Value $9.07Fund rank 20/100 · Data gapFallback financials|
SA 43/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $118.1M · quality 25.7/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 8/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

43/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 002215.SZLocal privado en este navegador · Shenzhen Noposion Crop Science Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9.1B

P/E

11.8x

↓

EV/EBITDA

9.7x

↓

ROE

15.6%

↑

Gross Margin

37.4%

↑

Debt/Equity

1.26

↑
52-Week Range$9
$9$14

TradingView lightweight chart

002215.SZ price, volumen y niveles de valoración

Último $9.240Periodo +62.4%
Fair value: $9.070

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.7%

FCF CAGR

—

FCF margin

4.1%

FCF / Net income

0.37x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.78B · net income $650.4M · FCF $239.7M

2022-FY → 2025-FY

Gross margin

37.4%+10.3% pts

Operating margin

18.2%— pts

Net margin

11.2%+3.5% pts

FCF margin

4.1%+21.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$5.78B$5.78B$5.29B$4.12B$4.27B
Net Income$650.4M$650.4M$584.6M$235.6M$328.4M
EBITDA$1.37B$1.37B$1.13B$611.6M$625.4M
EPS0.640.640.570.230.33
Gross Margin37.4%37.4%37.7%29.5%27.1%
Operating Margin18.2%18.2%———
Net Margin11.2%11.2%11.1%5.7%7.7%
Balance Sheet
Debt/Equity1.261.261.341.220.90
Current Ratio0.860.86———
Cash Flow
Free Cash Flow$239.7M$239.7M$118.1M$-344.9M$-730.3M
Returns
ROE15.6%15.6%15.3%6.3%9.0%
Valuation
P/E11.7811.7817.6334.7716.35
EV/EBITDA9.719.7112.3318.7411.87
P/B2.212.212.692.181.46
Growth & Yield
Revenue Growth9.3%9.3%28.4%-3.4%—
EPS Growth11.9%11.9%143.8%-28.7%—
Dividend Yield3.3%3.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

7.9%

razonable

EPS terminal req.

$0.80

Spread vs growth

4.1%

5Y implied EPS CAGR

8.7%

razonable

EPS terminal req.

$0.97

Spread vs growth

3.2%

10Y implied EPS CAGR

9.4%

razonable

EPS terminal req.

$1.57

Spread vs growth

2.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.4%

Total return

+0.4%

Start / end P/E

16.6x → 14.4x

EPS bridge

0.57 → 0.64

Residual

-1.6%

EPS growth+11.9%
Multiple rerating-13.2%
Dividend+3.3%
Residual / FX / buybacks / cross-term-1.6%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.